| Risk | Moderately High |
|---|---|
| Min SIP Amount | ₹500 |
| Expense Ratio | 2.44% |
| NAV | ₹53.85 (23 Oct 2020) |
|---|---|
| Fund Started | 19 Apr 2007 |
| Fund Size | ₹1,005 Cr |
| Name | Sector | Instrument | % Assets |
|---|---|---|---|
| Balkrishna Industries Ltd. | Automobile | Equity | 4.3% |
| Coromandel International Ltd. | Chemicals | Equity | 3.8% |
| Apollo Hospitals Enterprise Ltd. | Healthcare | Equity | 3.7% |
| Indraprastha Gas Ltd. | Energy | Equity | 3.3% |
| AIA Engineering Ltd. | Metals | Equity | 3.1% |
| Voltas Ltd. | Cons Durable | Equity | 3.0% |
| Ajanta Pharma Ltd. | Healthcare | Equity | 3.0% |
| L&T Technology Services Ltd. | Engineering | Equity | 3.0% |
| Muthoot Finance Ltd. | Financial | Equity | 2.8% |
| Vinati Organics Ltd. | Chemicals | Equity | 2.8% |
Invesco India Mid Cap Fund Growth is a Equity Mutual Fund Scheme launched by Invesco Mutual Fund. This scheme was made available to investors on 19 Apr 2007. Vinay Paharia is the Current Fund Manager of Invesco India Mid Cap Fund Growth fund.The fund currently has an Asset Under Management(AUM) of ₹1,005 Cr and the Latest NAV as of 23 Oct 2020 is ₹53.85.
The Invesco India Mid Cap Fund Growth is rated Moderately High risk. Minimum SIP Investment is set to 500. Minimum Lumpsum Investment is 1000. For units in excess of 10% of the investment, 1% will be charged for redemption within 1 year.
The scheme seeks to generate capital appreciation by investing predominantly in Midcap companies
Returns are taxed at 15%, if you redeem before one year. After 1 year, you are required to pay LTCG tax of 10% on returns of Rs 1 lakh+ in a financial year.